US beats EU on drug review times, approvals

7th April 2017 Uncategorised 0

US regulators have outpaced their European counterparts both on the number of new medicines approved and length of review times between 2011 and 2015, shows a new analysis published by the New England Journal of Medicine.

More: US beats EU on drug review times, approvals
Source: News